The Pharmaceutical giant say they are taking steps to resolve a multi-billion dollar cancer-related lawsuit with thousands of ...
Johnson & Johnson, which began selling Baby Powder in 1894, will end all sales of the talc-based product next year. Johnson & Johnson (JNJ) shares edged lower Friday after the consumer ...
Deal would resolve tens of thousands of lawsuits alleging company’s baby powder causes ovarian cancer ...
Plaintiffs have three months to vote on whether to approve a proposed legal settlement that would resolve nearly all talc lawsuits.
A subsidiary of Johnson & Johnson has proposed a settlement of $6.48 billion over 25 years for lawsuits alleging that its ...
Even looking at the nominal value of the latest potential talc-settlement—approximately $8.4 billion, which is then ...
(Reuters) - Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales of a product that drew ...
"Johnson & Johnson's baby powder is safe and asbestos-free. Studies of more than 100,000 men and women show that talc does not cause cancer or asbestos-related disease," the statement added.
Johnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies ...
A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement ...
CORRECTION: This article has been updated to reflect that Dr. Matthew Sanchez was questioned by attorney David Dearing, not Lance Oliver as previously stated. Johnson & Johnson, the New Jersey ...
Patricia Matthey appeared before a Sarasota jury in circuit court late Wednesday afternoon, displaying in front of her various medical supplies — intravenous tubing, needles, a colostomy bag ...